LPCN - Lipocine Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - LPCN (1535955)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
6 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2017-12-29
LPCNBass Gregory BrooksChief Commercial OfficerS - Sale+OE$3.47-3,7505,625-40%-$13,023
D
2017-12-29
LPCNPatel Mahesh V.CEO, PresS - Sale+OE$3.48-6,000722,112-1%-$20,867
D
2017-12-29
LPCNBrown Morgan REVP, CFOS - Sale+OE$3.47-2,81323,562-11%-$9,773
D
2017-12-29
LPCNHill Stephen ADirS - Sale+OE$3.47-1,2505,250-19%-$4,342
D
2017-12-29
LPCNOno Richard DanaDirS - Sale+OE$3.47-8754,875-15%-$3,033
D
2017-12-29
LPCNFink Jeffrey ArvinDirS - Sale+OE$3.47-938937-50%-$3,258
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top